These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24422285)

  • 1. [Current applications of PET/CT].
    Soussan M; Pop G; Eder V
    Rev Prat; 2013 Nov; 63(9):1199-207. PubMed ID: 24422285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body imaging modalities in oncology.
    Carty F; Shortt CP; Shelly MJ; Eustace SJ; O'Connell MJ
    Semin Musculoskelet Radiol; 2010 Mar; 14(1):68-85. PubMed ID: 20229442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET and PET/CT in pediatric oncology.
    Jadvar H; Connolly LP; Fahey FH; Shulkin BL
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers.
    Gaeta CM; Vercher-Conejero JL; Sher AC; Kohan A; Rubbert C; Avril N
    Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):352-66. PubMed ID: 24322792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of PET/CT in the development of novel anticancer drugs.
    Boss DS; Olmos RV; Sinaasappel M; Beijnen JH; Schellens JH
    Oncologist; 2008 Jan; 13(1):25-38. PubMed ID: 18245010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of malignant tumor metabolism: whole-body image fusion of DWI/CT vs. PET/CT.
    Reiner CS; Fischer MA; Hany T; Stolzmann P; Nanz D; Donati OF; Weishaupt D; von Schulthess GK; Scheffel H
    Acad Radiol; 2011 Aug; 18(8):940-6. PubMed ID: 21718953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated PET/CT: current applications and future directions.
    von Schulthess GK; Steinert HC; Hany TF
    Radiology; 2006 Feb; 238(2):405-22. PubMed ID: 16436809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-modality PET/CT instrumentation-today and tomorrow.
    Lonsdale MN; Beyer T
    Eur J Radiol; 2010 Mar; 73(3):452-60. PubMed ID: 20096520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated PET/CT and cancer imaging.
    De Wever W; Coolen J; Verschakelen JA
    JBR-BTR; 2009; 92(1):13-9. PubMed ID: 19358480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of PET and PET/CT in pediatric malignancies.
    Kumar R; Shandal V; Shamim SA; Halanaik D; Malhotra A
    Expert Rev Anticancer Ther; 2010 May; 10(5):755-68. PubMed ID: 20470007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
    Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
    J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of positron emission tomography chemistry: clinical and technical considerations and combination with computed tomography.
    Koukourakis G; Maravelis G; Koukouraki S; Padelakos P; Kouloulias V
    J BUON; 2009; 14(4):575-80. PubMed ID: 20148445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography/computed tomography: the current technology and applications.
    Mittra E; Quon A
    Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pulmonary nodules and lung cancer with one-inch crystal gamma coincidence positron emission tomography/CT versus dedicated positron emission tomography/CT.
    Moodie K; Cherk MH; Lau E; Turlakow A; Skinner S; Hicks RJ; Kelly MJ; Kalff V
    J Med Imaging Radiat Oncol; 2009 Feb; 53(1):32-9. PubMed ID: 19453526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET-CT for treatment planning in prostate cancer.
    Picchio M; Crivellaro C; Giovacchini G; Gianolli L; Messa C
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):245-68. PubMed ID: 19293771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT in diagnostic oncology.
    Messa C; Bettinardi V; Picchio M; Pelosi E; Landoni C; Gianolli L; Gilardi MC; Fazio F
    Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):66-75. PubMed ID: 15243404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different intravenous contrast media concentrations do not affect clinical assessment of 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans in an intraindividual comparison.
    Prechtel HW; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
    Invest Radiol; 2012 Sep; 47(9):497-502. PubMed ID: 22820678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.